Pharmaceutical Executive November 5, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

A Strategic Look at FDA’s Diversity Action Plan Guidance

In a video interview with Applied Clinical Trials, Jay Park and Rebecca Metcalfe of Core Clinical Sciences discussed their recent article published in JAMA titled, “Diversity Action Plans in Clinical Trials.” In addition to key takeaways from the article, Park and Metcalfe discussed the FDA’s new guidance for diversity action plans in clinical trials, the role of risk-based monitoring as a tool for improving diversity, and the importance of patient-reported outcomes.

Combatting Medical Misinformation: Strategies for Patient Education, Curriculum Integration, and Social Media Engagement

Pharmacy Times interviewed Julie Sibbesen, PharmD, a clinical pharmacy specialist in Enterprise Medication Use at WVU Medicine in Morgantown, West...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
Why Walgreens Is Reportedly Considering a Private Equity Buyer

Share This Article